Nevro Corp (NVRO)
4.52
+0.16
(+3.67%)
USD |
NYSE |
Nov 22, 16:00
4.515
0.00 (0.00%)
After-Hours: 20:00
Nevro Cash from Financing (Quarterly): -0.354M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -0.354M |
| June 30, 2024 | 1.997M |
| March 31, 2024 | -6.48M |
| December 31, 2023 | 48.70M |
| September 30, 2023 | -1.013M |
| June 30, 2023 | 4.122M |
| March 31, 2023 | -2.273M |
| December 31, 2022 | 1.374M |
| September 30, 2022 | 0.037M |
| June 30, 2022 | 2.885M |
| March 31, 2022 | -6.753M |
| December 31, 2021 | 3.276M |
| September 30, 2021 | -1.325M |
| June 30, 2021 | -169.86M |
| March 31, 2021 | -1.47M |
| December 31, 2020 | 5.139M |
| September 30, 2020 | 0.761M |
| June 30, 2020 | 324.83M |
| March 31, 2020 | 16.18M |
| December 31, 2019 | 21.39M |
| September 30, 2019 | 3.009M |
| June 30, 2019 | 5.921M |
| Date | Value |
|---|---|
| March 31, 2019 | 1.774M |
| December 31, 2018 | 1.299M |
| September 30, 2018 | 0.411M |
| June 30, 2018 | 4.318M |
| March 31, 2018 | 1.726M |
| December 31, 2017 | 2.594M |
| September 30, 2017 | 3.088M |
| June 30, 2017 | 3.408M |
| March 31, 2017 | 2.109M |
| December 31, 2016 | 5.073M |
| September 30, 2016 | 0.874M |
| June 30, 2016 | 138.58M |
| March 31, 2016 | 0.633M |
| December 31, 2015 | 2.242M |
| September 30, 2015 | 0.579M |
| June 30, 2015 | 119.93M |
| March 31, 2015 | 0.079M |
| December 31, 2014 | 152.37M |
| September 30, 2014 | -0.828M |
| June 30, 2014 | 0.508M |
| March 31, 2014 | 0.029M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-169.86M
Minimum
Jun 2021
324.83M
Maximum
Jun 2020
12.06M
Average
1.068M
Median
Cash from Financing (Quarterly) Benchmarks
| Inspire Medical Systems Inc | 9.89M |
| Inari Medical Inc | 2.386M |
| Stereotaxis Inc | 0.08M |
| Electromed Inc | -4.467M |
| Myomo Inc | -0.1995M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 2.732M |
| Cash from Investing (Quarterly) | -6.435M |
| Free Cash Flow | -56.61M |
| Free Cash Flow Per Share (Quarterly) | 0.0043 |
| Free Cash Flow to Equity (Quarterly) | -3.71M |
| Free Cash Flow to Firm (Quarterly) | 4.013M |
| Free Cash Flow Yield | -34.08% |